TP53 and cancer: Moreover, a potent and selective DNA-PK inhibitor, that selectively blocks the NHEJ for repair of DSB, induced an immunomodulatory phenotype and elevated the expression of PD-L1 protein via cGAS-STING pathway activation in irradiated p53-mutant cancer cells [172].